BrainStorm Cell Therapeutics
BCLI
#10185
Rank
A$10.84 M
Marketcap
$1.90
Share price
-6.50%
Change (1 day)
-87.16%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -A$14.84 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$40.16 Million, an increase over its 2021 earnings that were of -A$40.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$14.84 Million
2022 -A$40.16 Million-0.74%
2021 -A$40.46 Million-23.12%
2020 -A$52.62 Million36.8%
2019 -A$38.47 Million66.71%
2018 -A$23.07 Million181.66%
2017 -A$8.2 Million-0.6%
2016 -A$8.25 Million-41.31%
2015 -A$14.04 Million-8.22%
2014 -A$15.3 Million89.74%
2013 -A$8.07 Million42.27%
2012 -A$5.67 Million-12.45%
2011 -A$6.48 Million63.04%
2010 -A$3.97 Million35.52%
2009 -A$2.93 Million-48.99%
2008 -A$5.75 Million-44.39%
2007 -A$10.33 Million
2005 -A$5.35 Million-91.44%
2004 -A$62.49 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$1.14 B-7,086.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.98 Billion 5,869.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.31 Billion 7,905.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.15 B-19,399.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 1,060.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.43 Billion 2,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA